Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
INVO FertilityIVF +7.18%35 Equity-to-Asset is 0.61 as of Mar. 2026. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $115.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, INVO Fertility ranks worse than 54.04% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. INVO Fertility's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $15.02 Mil. INVO Fertility's Total Assets for the quarter that ended in Mar. 2026 was $24.66 Mil.
Therefore, INVO Fertility's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.61.
The historical rank and industry rank for INVO Fertility's Equity-to-Asset or its related term are showing as below:
IVF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -26.4 Med: -0.13 Max: 0.7
Current: 0.61
During the past 13 years, the highest Equity to Asset Ratio of INVO Fertility was 0.70. The lowest was -26.40. And the median was -0.13.
IVF's Equity-to-Asset is ranked worse than 54.04% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs IVF: 0.61
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
INVO Fertility Equity-to-Asset Related Terms
INVO Fertility Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for INVO Fertility's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF vs AMIX, AEMD, NUMD: Equity-to-Asset Comparison
For the Medical Devices subindustry, INVO Fertility's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
INVO Fertility Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where INVO Fertility's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
INVO Fertility's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INVO Fertility (IVF) has a Equity-to-Asset of 0.61 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on INVO Fertility and its competitors. According to the industry distribution chart, INVO Fertility ranks #461 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 54%.
Is INVO Fertility's Equity-to-Asset too high?
INVO Fertility's current Equity-to-Asset is 0.61. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. INVO Fertility's value of 0.61 is 4.7% below this industry median. Based on the distribution chart, INVO Fertility ranks #461 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's Equity-to-Asset compare to AMIX and AEMD?
According to the Medical Devices & Instruments industry distribution chart, INVO Fertility ranks #461 out of 853 companies for Equity-to-Asset. This places INVO Fertility in the lower half of its industry. The industry median Equity-to-Asset is 0.64. INVO Fertility's value of 0.61 is 4.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. INVO Fertility's current Equity-to-Asset of 0.61 is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on INVO Fertility and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. INVO Fertility's current Equity-to-Asset is 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $115.66, compared to a current price of $1.03 — trading 99.1% below its estimated fair value. The current Equity-to-Asset is 0.61 and 4.7% below the Medical Devices & Instruments industry median of 0.64. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For INVO Fertility (IVF), the current Equity-to-Asset is 0.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is INVO Fertility (IVF) Overvalued in 2026?
Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued.
The current stock price of $1.03 is trading 99.1% below its estimated GF Value™ of $115.66.
GuruFocus considers INVO Fertility to be Possible Value Trap.
Key valuation signals for IVF:
Equity-to-Asset: 0.61
GF Value™: $115.66 vs. price of $1.03 (99.1% below fair value)
Industry Position: 4.7% below the Medical Devices & Instruments median (#461 of 853)
No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score
Get the complete analysis for IVF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVF has been successfully added to your 
